Dr Lawrence S, Kegeles, MD | |
1051 Riverside Drive, Unit 31, New York, NY 10032 | |
(212) 543-5497 | |
(212) 568-6171 |
Full Name | Dr Lawrence S, Kegeles |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 1051 Riverside Drive, New York, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003037755 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 193253-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Lawrence S, Kegeles, MD 127 W. 96th St., Apt. 13d, New York, NY 10025 Ph: (212) 543-5497 | Dr Lawrence S, Kegeles, MD 1051 Riverside Drive, Unit 31, New York, NY 10032 Ph: (212) 543-5497 |
News Archive
ImplementHIT will roll out OptimizeHIT, physician electronic health record (EHR) elearning solutions, at HIMSS 2011 in Orlando, FL, February 20-24 in booth 3385. This new patent-pending solution will deliver bold new functionality scaled to small physician practices with 20 doctors or fewer, empowering them to achieve meaningful use of qualified EHRs.
The drug tamoxifen appears to kill a fungus associated with a deadly brain infection that afflicts HIV/AIDS patients, according to a University of Rochester study published online today by mBio, the journal of the American Society for Microbiology.
LifeBridge Health has been honored for a second straight year with three prestigious Partner for Change Awards for its commitment to protecting the environment and human health by Practice Greenhealth, a national membership organization for health care facilities dedicated to environmentally responsible operations. The awards are given each year for outstanding environmental achievements in the health care sector.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
› Verified 7 days ago
Dr. Jahannaz Dastgir, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 710 W 168th St, New York, NY 10032 Phone: 646-426-3876 Fax: 212-342-6865 | |
Dr. Risa Ribakove, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 135 E 12th St, Second Floor, New York, NY 10003 Phone: 212-229-1671 | |
Dr. Laura Raquel Sirulnik, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 15 W 63rd St Apt 33a, New York, NY 10023 Phone: 646-258-8535 | |
Dr. Amanda Moberg Wilson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 21 W 86th St, Suite 209, New York, NY 10024 Phone: 917-715-2886 | |
Dr. Jose Dtm Gutierrez, MD, MPH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 710 W 168th St, 6th Floor, New York, NY 10032 Phone: 212-305-8389 | |
Nathaniel Mendelsohn, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 950 Park Ave, New York, NY 10028 Phone: 646-389-1447 |